Matt Kaeberlein

---

November 22, 2017

AAAS names 8 UW researchers as fellows in 2017

Eight University of Washington researchers are among the 396 new fellows of the American Association for the Advancement of Science, announced this week.

---

November 14, 2013

FDA-approved immune-modulating drug unexpectedly benefits mice with fatal mitochondrial defect

Rapamycin, an anti-rejection drug for organ transplant patients, has now been shown to increases survival in and delayed symptoms of Leigh’s syndrome. The drug appears to cause a metabolic switch that bypasses the mitochondrial deficiency.

---